Go to deals
Healthcare

MedAxiom has been acquired by American College of Cardiology

The private shareholders of MedAxiom have sold the company to American College of Cardiology, Inc.

MedAxiom was founded in 2001 and is the nation’s leading cardiovascular performance community serving physician practices by providing expert consulting, networking and membership services including data analytics, program excellence tools and educational events to improve business and patient care outcomes.

American College of Cardiology is a trade association that caters to cardiovascular professionals to learn, grow and share knowledge about cardiovascular care and heart health. It also reviews and offers certification courses focusing on cardiovascular diseases. The association helps in the formation of cardiology guidelines, clinical data standards and health policies. Additionally, it publishes cardiovascular journals which focus on cardiovascular diseases, including original clinical studies, translational investigations with clear clinical relevance, state-of-the-art papers, review articles, and editorials interpreting and commenting on the research presented. American College of Cardiology was founded in 1949 and is based in Washington, DC.

Oaklins’ teams in Jacksonville and Savannah acted as financial advisors to MedAxiom in this transaction.

Parties
“We are very pleased with the transaction in all respects. We never could have crossed the finish line without the Oaklins team advising us on tough issues, rolling up their sleeves to keep the deal moving and managing the transaction process.”

Jennifer Linville

Founding CEO, MedAxiom

Talk to the deal team

Bert M. Tenenbaum

Principal
Savannah, United States
Oaklins Heritage

Doug Kravet

Principal
Jacksonville, United States
Oaklins Heritage

Howard C. Serkin

Principal
Jacksonville, United States
Oaklins Heritage

Related deals

MEDIK Hospital Design Group has been acquired by STERIS
Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more
SLT has been acquired by Indutrade
Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more